Merit Medical Launches the Aspira® Evacuated Drainage Bottle
06 Septembre 2023 - 3:25PM
Merit Medical Systems, Inc. (NASDAQ: MMSI), a leading global
manufacturer and marketer of healthcare technology,
today announced U.S. commercial release of its Aspira Bottle.
The new evacuated drainage bottle is the latest addition to
Merit’s drainage portfolio. Offering a wide range of intervention
products, solutions, and accessories, the comprehensive portfolio
includes the Aspira System and ReSolve® line, thoracostomy,
thoracentesis, and paracentesis trays and sets as well as bags and
other support products.
The Aspira Drainage System is indicated for drainage of
recurrent and symptomatic pleural effusions (fluid buildup outside
the lungs) and malignant ascites (fluid buildup in the abdomen due
to cancer). Individuals with these conditions commonly require
frequent in-hospital drainage. Patient care may also include
prolonged hospitalization or other treatments that can
significantly reduce quality of life and diminish remaining
survival.
When used with the Aspira System, the Aspira Bottle can provide
the compassionate option to self-treat in the comfort of home,
giving patients more time with loved ones. The bottle also offers
convenience with its ease-of-use and advanced design that requires
23% less storage space than the leading drainage bottle on the
market.1 To further optimize patient comfort, the Aspira Bottle
allows users to control drainage speed, helping to minimize
discomfort and pain associated with high vacuum pressure
drainage.
Learn more about the Aspira Bottle.
“The Aspira Bottle is one more way Merit strives to improve
patient care, which includes providing the option of at-home care,”
said Fred P. Lampropoulos, Merit Medical’s Chairman and CEO.
“Bringing comfort to patients at every stage of life speaks to the
heart of who Merit is—we care.”
ABOUT MERIT MEDICAL Founded in 1987, Merit Medical Systems, Inc.
is engaged in the development, manufacture, and distribution of
proprietary disposable medical devices used in interventional,
diagnostic, and therapeutic procedures, particularly in cardiology,
radiology, oncology, critical care, and endoscopy. Merit serves
client hospitals worldwide with a domestic and international sales
force and clinical support team totaling in excess of 700
individuals. Merit employs approximately 7,100 people
worldwide.
TRADEMARKS Unless noted otherwise, trademarks and registered
trademarks used in this release are the property of Merit Medical
Systems, Inc. and its subsidiaries in the United States and other
jurisdictions.
CONTACTS PR/Media Inquiries Sarah Comstock Merit
Medical +1-801-432-2864 | sarah.comstock@merit.com
INVESTOR INQUIRIES Mike Piccinino, CFA, IRC Westwicke
- ICR +1-443-213-0509 | mike.piccinino@westwicke.com
1. Data on File.
Merit Medical Systems (NASDAQ:MMSI)
Graphique Historique de l'Action
De Mai 2024 à Juin 2024
Merit Medical Systems (NASDAQ:MMSI)
Graphique Historique de l'Action
De Juin 2023 à Juin 2024